IRF4 and glioma: Moreover, the formulation better countered the immunosuppressive glioma microenvironment by reducing M2 macrophage polarization via the suppression of IRF4 transcription and diminished phosphorylation of STAT6, STAT3, and AKT, thereby undermining a key mechanism of glioma immune evasion.